BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9
2979 results:

  • 1. Racial and Ethnic Disparities in the Incidence of Anti-NMDA Receptor Encephalitis.
    Alsalek S; Schwarzmann KB; Budhathoki S; Hernandez-Lopez V; Smith JB; Li BH; Langer-Gould A
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200255. PubMed ID: 38728608
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical, Morphological and Molecular Features of Spitz tumors.
    Donati M; Mansour B; Hagstrom M; Gerami P; Kazakov DV
    Cesk Patol; 2024; 60(1):35-48. PubMed ID: 38697826
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship Survey.
    Jimenez AE; Cicalese KV; Jimenez MA; Chakravarti S; Kuo CC; Lozinsky S; Schwab JH; Knowlton SE; Rowan NR; Mukherjee D
    Neurosurg Focus; 2024 May; 56(5):E12. PubMed ID: 38691854
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant methioninase and a Low-methionine Diet.
    Sato M; Han Q; Mizuta K; Mori R; Kang BM; Morinaga S; Kobayashi N; Ichikawa Y; Nakajima A; Hoffman RM
    In Vivo; 2024; 38(3):1459-1464. PubMed ID: 38688589
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.
    Tropeano MP; Raspagliesi L; Bono BC; Baram A; Rossini Z; Franzini A; Navarria P; Clerici E; Bellu L; Simonelli M; Scorsetti M; Riva M; Politi LS; Pessina F
    Acta Neurochir (Wien); 2024 Apr; 166(1):196. PubMed ID: 38676720
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
    Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
    Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::met fusion.
    Chapman N; Greenwald J; Suddock J; Xu D; Markowitz A; Humphrey M; Cotter JA; Krieger MD; Hawes D; Ji J
    Acta Neuropathol Commun; 2024 Apr; 12(1):63. PubMed ID: 38650040
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A comparison study of dynamic [
    Pan Y; Dang H; Zhou H; Fu H; Wu S; Liu H; Zhang J; Wang R; Tian Y; Xu B
    J Cancer Res Clin Oncol; 2024 Apr; 150(4):208. PubMed ID: 38647690
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FETPY: a Diiron(I) Thio-Carbyne Complex with Prominent Anticancer Activity In Vitro and In Vivo.
    Mihajlović E; Biancalana L; Jelača S; Chiaverini L; Dojčinović B; Dunđerović D; Zacchini S; Mijatović S; Maksimović-Ivanić D; Marchetti F
    J Med Chem; 2024 May; 67(9):7553-7568. PubMed ID: 38639401
    [No Abstract]    [Full Text] [Related]  

  • 10. Lidocaine attenuates TMZ resistance and inhibits cell migration by modulating the met pathway in glioblastoma cells.
    Chen MS; Chong ZY; Huang C; Huang HC; Su PH; Chen JC
    Oncol Rep; 2024 May; 51(5):. PubMed ID: 38606513
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Strategies to improve diagnosis and access to treatment of retinoblastoma in low- and middle-income countries: A systematic review.
    Rabelo BS; de Alvarenga KAF; Fernando Lopes L; Guimarães Ribeiro A; de Sá Rodrigues KE
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30987. PubMed ID: 38594882
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Minimally invasive keyhole approach for supramaximal frontal glioma resections: technical note.
    Merenzon MA; Mendez Valdez MJ; Chandar J; Lu VM; Marco Del Pont F; Morell AA; Eichberg DG; Daggubati L; Benjamin CG; Shah AH; Ivan ME; Komotar RJ
    J Neurosurg; 2024 Apr; 140(4):949-957. PubMed ID: 38564815
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Maximal cardiopulmonary exercise testing in glioblastoma patients undergoing chemotherapy: assessment of feasibility, safety, and physical fitness status.
    Jost J; Völker K; Brandt R; Stummer W; Urbschat S; Ketter R; Wiewrodt D; Wiewrodt R;
    J Neurooncol; 2024 May; 168(1):35-45. PubMed ID: 38561565
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma.
    Sacco JJ; Jackson R; Corrie P; Danson S; Evans TRJ; Ochsenreither S; Kumar S; Goodman A; Larkin J; Karydis I; Steven N; Lorigan P; Plummer R; Patel P; Psarelli E; Olsson-Brown A; Shaw H; Leyvraz S; Handley L; Rawcliffe C; Nathan P
    Eur J Cancer; 2024 May; 202():114009. PubMed ID: 38547774
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A systematic review of high impact CpG sites and regions for MGMT methylation in glioblastoma [A systematic review of MGMT methylation in GBM].
    Gibson D; Vo AH; Lambing H; Bhattacharya P; Tahir P; Chehab FF; Butowski N
    BMC Neurol; 2024 Mar; 24(1):103. PubMed ID: 38521933
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
    Straube C; Combs SE; Bernhardt D; Gempt J; Meyer B; Zimmer C; Schmidt-Graf F; Vajkoczy P; Grün A; Ehret F; Zips D; Kaul D
    J Neurooncol; 2024 May; 168(1):49-56. PubMed ID: 38520571
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Preoperative 11 C-methionine PET-MRI in Pediatric Infratentorial tumors.
    Beuriat PA; Flaus A; Portefaix A; Szathmari A; Janier M; Hermier M; Lorthois-Ninou S; Scheiber C; Isal S; Costes N; Merida I; Lancelot S; Vasiljevic A; Leblond P; Faure Conter C; Saunier C; Kassai B; Vinchon M; Di Rocco F; Mottolese C
    Clin Nucl Med; 2024 May; 49(5):381-386. PubMed ID: 38498623
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Intraoperative ultrasound for surgical resection of high-grade glioma and glioblastoma: a meta-analysis of 732 patients.
    Pichardo-Rojas PS; Zarate C; Arguelles-Hernández J; Barrón-Lomelí A; Sanchez-Velez R; Hjeala-Varas A; Gutierrez-Herrera E; Tandon N; Esquenazi Y
    Neurosurg Rev; 2024 Mar; 47(1):120. PubMed ID: 38498065
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining
    Feng L; Yang X; Wang C; Zhang H; Wang W; Yang J
    Pediatr Radiol; 2024 May; 54(5):805-819. PubMed ID: 38492045
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genetically Distinct Oligosarcoma Arising from Oligodendroglioma: Systematic Review & Illustrative Case Example.
    Evans AR; Prather KY; Battiste J; Fung KM; Dunn IF; Graffeo CS
    World Neurosurg; 2024 May; 185():e1093-e1100. PubMed ID: 38490447
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 149.